CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-29 | Hyman Steven Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-06-29 | PIERCE GLENN Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-04-12 | Third Rock Ventures III, L.P. 10% owner | Other disposition | −920,000 | 9,391,176 | ||
| 2017-04-12 | LEVIN MARK J Director | Other disposition | −920,000 | 9,391,176 | ||
| 2017-02-08 | PAUL STEVEN M President and CEO | Grant or award · Stock Option (Right to Buy) | +240,000 | $11.83 | $2.8M | 240,000 |
| 2017-01-03 | Henderson Jane Sr. V.P. & CFO | Grant or award · Stock Option (Right to Buy) | +214,000 | 214,000 | ||
| 2017-01-03 | PIERCE GLENN Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2017-01-03 | DIXON WENDY L Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2016-12-19 | LEVIN MARK J Director | Other disposition | −750,000 | 10,311,176 | ||
| 2016-12-19 | Third Rock Ventures III, L.P. 10% owner | Other disposition | −750,000 | 10,311,176 | ||
| 2016-06-15 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2016-06-15 | GERAGHTY JAMES A Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2016-06-15 | LEVIN MARK J Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2016-06-15 | KARSEN PERRY A Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2016-06-15 | Hyman Steven Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2016-02-01 | PAUL STEVEN M President and CEO | Grant or award · Stock Options (Right to Buy) | +200,000 | $11.09 | $2.2M | 200,000 |
| 2016-02-01 | Goater Jeff Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +40,000 | $11.09 | $444K | 40,000 |
| 2016-02-01 | Goater Jeff Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +25,000 | $11.09 | $277K | 65,000 |
| 2016-01-14 | PAUL STEVEN M President and CEO | Purchase | +10,000 | $14.07 | $141K | 872,351 |
| 2015-11-16 | LEVIN MARK J Director | Conversion | +10,588,235 | 11,061,176 |
Page 18 of 19 · 368 trades